patients admitted to this study fulfilled our own criteria (Ansell & Bywaters 1959) . At the present time, 168 have been seen fifteen years from the onset of their disease and 84 at twenty years. This is a relatively short time but it does offer some information on prognosis. A summary of the fifteen-year follow up is now given:
There was a total of 101 females and 67 males. Seventeen, 10 females and 7 males, had died prior to the fifteen-year follow up. Infection of various types was the most common cause of death and this accounted for 7, 5 of whom were on corticosteroids; the second most common cause was renal failure due to amyloidosis, from which 6 patients died; 2 had died from unrelated causes (acute renal cortical necrosis; postoperatively following repair of congenital aortic stenosis), while another patient died of uremia, the exact cause of which was never determined. Only one was considered to have died as a direct result of his Still's disease.
As one male and one female could not be traced a total of 90 females and 59 males were available for assessment. This included a clinical appraisal, assessment of function, urine blood and X-ray examinations. The functional capacity was designated 5 if there was no incapacity, 4 if so slight that it did not interfere with leading a normal life. Seventy of the 90 girls and 52 of the 59 boys fell into the top two categories. Twenty, 16 girls and 4 boys, were in functional status 3 and had had their lives considerably modified being severely incapacitated as a result of the disease, while a total of 5 had wheelchair/crutch existences and two were bedfast; one of these last had an associated mental abnormality. As judged by the presence of soft tissue swelling around the joints and an ESR above 20 mm in 1 hour (Westergren), in 19 of the 90 girls and 17 of the 59 boys the disease was classed as active, whereas in the remainder it was considered inactive. Residua, either clinical or radiological, were present in 90 of the 113 inactive. Rheumatoid factor tests were positive in only 6 males and 9 females. Chronic iridocyclitis had occurred in 8 cases (4 males and 4 females) and acute iridocyclitis, often recurrent, in 4, all males. In addition to the 6 who had died from amyloidosis 7 others had been demonstrated as suffering from it. Psoriasis had developed in 3 patients and ankylosing spondylitis in 9.
Reviewing the pattern of illness, it seemed that 50 had had an acute illness, which had settled within five years; it was among these that the patients were seen without clinical or radiological residua; this always raises the question as to whether they had really suffered from Still's disease! In 37 the course had been one of recurrent bouts of activity with intervals of good health varying from months to years. Forty-four had chronic seronegative arthritis which remained active for more than five years, but many of these had become inactive at varying periods after that time. In 10 patients, 6 of whom were female, the pattern of illness had been more like that of adult rheumatoid arthritis with positive rheumatoid factor tests, the early development of erosions and occasionally nodules and vascular lesions. Eight, 6 of whom were male, had developed ankylosing spondylitis while one of the patients who had died had developed ankylosing spondylitis and psoriasis prior to death. Amyloidosis occurred in all groups but was most common among the chronic, active, seronegative cases.
To summarize, Still'sdisease is probably best regarded as a syndrome characterized by polyarthritis with or without systemic manifestations. The majority of such patients recover sufficiently to lead reasonably normal lives; some die from intercurrent infection but the most serious complication is amyloidosis which is usually fatal. A few patients, particularly the younger with an acute onset, settle quickly but the majority persist as a seronegative arthritis which may remit at any time leaving varying degrees of residua. Some, particularly males, may later develop ankylosing spondylitis while a few, particularly females, have a disease resembling adult rheumatoid arthritis; these last tend to persist active. 
Henmophilia
Hemophilia is a hereditary bleeding state due to deficiency or total lack of an essential bloodclotting factor called antihimophilic globulin (AHG) or Factor VIII. The condition is inherited as a sex-linked recessive character and-thus mainly affects males. Cases of female htmophilia have arisen in the offspring of marriages between affected males and female carriers of the disease. Since the incidence of hemophilia is very low (about 2 per 100,000 of the population) such marriages are rare. A second disease, Christmas disease, due to deficiency of another essential blood-clotting factor (Factor IX), is inherited in the same way as heemophilia and has the same clinical features. It is distinguishable only by laboratory tests.
The clinical features characteristic of these diseases are due to the hemorrhagic conse-quences. Severely affected patients (those with less than 1% of the deficient factor) suffer apparently spontaneous bleeding into muscles and joints which recurs progressively throughout childhood and without specific treatment leads to crippling by adolescence. Before 1940 the outlook for the h#mophilic patient was poor and the average expectation of life was 16 years; it was thus essentially a disease of childhood.
In recent years the possibility of treating patients with hcmophilia or Christmas disease has increased greatly. The reasons for this improvement include a better understanding of the theory of blood coagulation and in particular the invention of techniques for the assay of Factors VIII and IX. These advances have made it possible to study methods for the preparation of concentrates of Factors VIII and IX from human and animal blood and to correlate the results of laboratory tests with the clinical effectiveness oftreatment. Another advance which has been crucial to the development of treatment for homophilic patients has been the use of plastic containers in blood transfusion which permit the safe use of all blood constituents. Thus the red cells may be used for one patient and the plasma, either whole or fractionated, may be usd for another. Coincident with the grater availability of human plasma came the development of a very simple method for concentrating Factor VIII from human plasma making a product referred to as cryoprecipitate which is now widely available.
The present position is as follows: (1) Accumulated clinical experience has defined the plasma concentrations of Factors VIII and IX required to control various sorts of bleeding. In dangerous situations this treatment must be controlled by laboratory testing.
(2) Although the supply of therapeutic material has much increased so that there is now a reasonable supply of, Factor VIII, there is still need for some economy in its use. Factor IX is still very scarce and an increase in supply is needed. Fortunately patients with Christmas disease are rare.
(3) Although the availability of therapeutic materials now makes treatment possible in all large hospitals, it is desirable for the treatment of these patients to be localized as far as possible in special centres.
The last of these propositions requires some amplification. The hamophilic patient bleeds because his blood coagulation mechanism is abnormal. The correction of this defect is associated with cessation of bleeding. These are simple facts but hmmophilia and Christmas disease are still extremely dangerous diseas in the management of which skill and experience are of paramount importance. The two main categories of treatment required by these patients are: (1) Treatment for spontaneous bleeding that may lead to crippling deformity. (2) Treatment for conditions directly endangering life (e.g. surgery, serious accidents, bleeding into dangerous sites).
Since the crippling of hamophilic or Christmas disease patients is caused by bleeding into joints and muscles it is now generally felt that this treatment should be given as an emergency and very early in the development of the bleed. Many patients have such bleeds quite frequently and each episode must be treated. This means that intravenous therapy of the right material must be given at short notice at any hour of the day or night. This in turn means that when the patient presents at a hospital he must very soon meet someone who knows all about him and get his treatment without delay. This is not easy to arrange in most general hospitals but must be a feature of those hospitals which have hemophilia centres.
For the treatment of serious lesions there is no doubt that experience is vital. One miscalculation by any member of staff may cost a life. The surgeons, nurses and laboratory doctors must all know of their patient's special problems. Such knowledge cannot be acquired without reasonable practice. An equally important question is that of time and facility for attention to detail. A dose of therapeutic material may be expected to have a certain predictable effect. In practice this effect may not be achieved for several reasons. The activity of the dose material may be poor, the patient may be bleeding and thus losing the material as it is given, the patient may have an inhibitor to Factor VIII or to Factor IX. Thus, for every dose given, it is necessary to assay the activity of the dose material and to assess the patient's response. This time-consuming laboratory work is not possible in most hospitals.
The increased availability of therapeutic materials for the treatment of patients with coagulation defects thus poses a problem in medicine. The increase necessitates a reassessment of the needs of h2emophilia centres. A centre which should give emergpncy treatment to a number of patients on a 24-hour basis cannot be effective without special staff. The solutions will vary from one place to another but it is certain that solutions should be sought with urgency.
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